Editorial: High-Throughput Sequencing-Based Investigation of Chronic Disease Markers and Mechanisms

[No abstract available]

Авторы
Orlov Y.L. , Chen W.-L. , Sekacheva M.I. , Cai G. , Li H.
Журнал
Frontiers in Genetics
Издательство
Frontiers Media S.A.
Язык
Английский
Статус
Опубликовано
Ссылка
Внешняя ссылка
DOI
10.3389/FGENE.2022.922206
Номер
922206
Том
13
Год
2022
Организации
  • 1 First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
  • 2 Novosibirsk State University, Novosibirsk, Russian Federation
  • 3 Institute of Cytology and Genetics SB RAS, Novosibirsk, Russian Federation
  • 4 Agrarian and Technological Institute, Peoples’ Friendship University of Russia, Moscow, Russian Federation
  • 5 Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
  • 6 Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, United States
  • 7 Bio-ID Center, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
Ключевые слова
biomarker development; chronic disease; disease mechanism; high-throughput sequencing; omics study; prognosis prediction
Цитировать
ГОСТ MLA RIS BibTex
Поделиться

Другие записи